Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Atopic Eczema”

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05702268
What this trial is testing

Pharmacodynamic Blood Characteristics of ICP-332 in Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Moderate to Severe Atopic Dermatitis
Beijing InnoCare Pharma Tech Co., Ltd. 75
Large-scale testing (Phase 3)Active Not RecruitingNCT06407934
What this trial is testing

Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Dermatitis Atopic
Sanofi 1,541
Testing effectiveness (Phase 2)Ended earlyNCT03809663
What this trial is testing

A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Amgen 251
Large-scale testing (Phase 3)Study completedNCT05398445
What this trial is testing

A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE)

Who this might be right for
Atopic Dermatitis
Amgen 769
Not applicableLooking for participantsNCT06988605
What this trial is testing

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

Who this might be right for
Atopic Dermatitis
Galderma R&D 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT07193589
What this trial is testing

A Phase II Clinical Study Evaluating of ZL-82 Tablets in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Chengdu Zenitar Biomedical Technology Co., Ltd 111
Post-approval studies (Phase 4)Study completedNCT05507580
What this trial is testing

Assess Treat-to-Target and Dosing Flexibility of Oral Upadacitinib Tablets in Adult Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
AbbVie 461
Post-approval studies (Phase 4)Study completedNCT04718870
What this trial is testing

Dupilumab-PEdiatric Skin Barrier Function and LIpidomics STudy in Patients With Atopic Dermatitis

Who this might be right for
Dermatitis Atopic
Sanofi 41
Large-scale testing (Phase 3)Study completedNCT04392154
What this trial is testing

Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 1,153
Testing effectiveness (Phase 2)Active Not RecruitingNCT07230860
What this trial is testing

JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Janssen Research & Development, LLC 189
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07465120
What this trial is testing

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase Ⅱ Clinical Study to Evaluate the Efficacy and Safety of CMS-D001 in Adult Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Moderate to Severe Atopic Dermatitis
Dermavon Holdings Limited 160
Early research (Phase 1)Study completedNCT01259323
What this trial is testing

Sequential Ascending Dose Study to Assess the Safety and Tolerability of REGN668 (SAR231893) in Patients With Atopic Dermatitis

Who this might be right for
Dermatitis
Regeneron Pharmaceuticals 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT06956196
What this trial is testing

Study of Stapokibatrt in Children Subjects With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Keymed Biosciences Co.Ltd 240
Testing effectiveness (Phase 2)Active Not RecruitingNCT07277660
What this trial is testing

A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
UCB Biopharma SRL 165
Testing effectiveness (Phase 2)Study completedNCT06101823
What this trial is testing

Phase 2a Study of Efficacy and Safety of OpSCF in Moderate to Severe AD (Atopic Dermatitis)

Who this might be right for
Atopic Dermatitis
Insmed Incorporated 50
Large-scale testing (Phase 3)Study completedNCT05958407
What this trial is testing

A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy

Who this might be right for
Atopic DermatitisAtopic Hand Eczema
LEO Pharma 235
Not applicableNot Yet RecruitingNCT07550452
What this trial is testing

Efficacy and Safety of Switching to Ivarmacitinib in Patients With Moderate-to-Severe Atopic Dermatitis With Inadequate Response to Interleukin-4 Receptor Alpha(IL-4Rα) Inhibitors: A Prospective, Multicenter, Real-World Study

Who this might be right for
Atopic Dermatitis (AD)
Peking University People's Hospital 300
Testing effectiveness (Phase 2)Study completedNCT03562377
What this trial is testing

Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)

Who this might be right for
Atopic Dermatitis
LEO Pharma 215
Large-scale testing (Phase 3)WithdrawnNCT04666675
What this trial is testing

Oral Upadacitinib Tablets to Assess Change in Disease State in Participants Aged 12-75 Years With Moderate to Severe Atopic Dermatitis in Brazil

Who this might be right for
Atopic Dermatitis (AD)
AbbVie
Testing effectiveness (Phase 2)Study completedNCT03747575
What this trial is testing

Assess the Efficacy and Safety of MSTT1041A in Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Genentech, Inc. 65
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation